share_log

鲁抗医药(600789.SH):获得药品注册证书及化学原料药上市申请批准通知书

Shandong Lukang Pharmaceutical (600789.SH): Obtained pharmaceutical registration certificate and approval notice for the listing application of chemical raw materials.

Gelonghui Finance ·  Aug 19 05:31

On August 19th, Gelunhui reported that Shandong Lukang Pharmaceutical (600789.SH) has received the Drug Registration Certificate for moxifloxacin hydrochloride tablets issued by the National Medical Products Administration and the Approval Notice for the Listing Application of moxifloxacin hydrochloride active pharmaceutical ingredient for chemical raw materials. Moxifloxacin hydrochloride is a fourth-generation quinolone antibiotic with a bactericidal mechanism that interferes with topoisomerase II and IV.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment